metastatic EGFR-mutant/BRAF V600E lung adenocarcinoma

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

June, 2025

metastatic EGFR-mutant/BRAF V600E lung adenocarcinoma

May 26, 2024, 06:31 | Insight

Vivek Subbiah: Impressive response to dabrafenib, trametinib, and osimertinib in a metastatic EGFR-mutant/BRAF V600E lung adenocarcinoma

Vivek Subbiah shared a post on X/Twitter: "Impressive response to dabrafenib, trametinib, and osimertinib in a…

All: 1 Posts: 1 - 100

'

MATTERHORN Trial at ASCO 2025: Durvalumab plus FLOT Shows Significant Improvement of EFS in Resectable Gastric and GEJ Cancer Treatment

'

15 Posts Not to Miss from the 2nd Day of ASCO 2025

'

15 Posts Not to Miss from the 1st Day of ASCO 2025

'

Wafik El-Deiry: Inside Yvonne Award Ceremony 2025

'

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023